WATCoin (WAT) news

Waters Says US FDA Clearance Obtained for Leukemia, Lymphoma Clinical Tests

Waters Files Initial Beneficial Ownership Statement for Steven Conly, SVP of Waters Biosciences

RBC Raises Price Target on Waters to $525 From $475, Keeps Outperform Rating

WATERS <WAT.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $460 FROM $440

WATERS CORP <WAT.N>: STIFEL RAISES TARGET PRICE TO $470 FROM $420

WATERS CORP <WAT.N>: LEERINK PARTNERS RAISES TARGET PRICE TO $500 FROM $450

WATERS CORP <WAT.N>: JP MORGAN RAISES TARGET PRICE TO $470 FROM $435

WATERS CORP <WAT.N>: RBC RAISES TARGET PRICE TO $525 FROM $475

BUZZ - Waters shares rise after raising full-year forecast, third quarter results exceed expectations

Waters Q3 2026 net income drops 46% to $81 million

BRIEF-Waters Q3 Adjusted EPS USD 4.1 Vs. IBES Estimate USD 4

Waters Corp Sees FY Adj EPS $14.60-Adj EPS $14.70 >WAT

Waters Corp Sees FY Rev $6.48B-$6.5B >WAT

Waters Corp 3Q Rev $1.77B >WAT

Waters Corp 3Q Adj EPS $4.10 >WAT

Waters Corp Sees 4Q Adj EPS $4.58-Adj EPS $4.68 >WAT

Waters Corp 3Q EPS 82c >WAT

Waters Corp: Financial Terms of MOBILion Transaction Not Disclosed >WAT

Waters acquires MOBILion Systems to expand proteomics capabilities

U.S. Earnings Preview: Before Market Open Nov. 3

Waters Fiscal Q3 Non-GAAP Earnings, Revenue Rise; Issues Q4 Guidance; Raises Fiscal 2026 Outlook

Waters Acquires MOBILion Systems to Expand Proteomics Business

--GUIDANCE: (WAT) Waters Expects 2026 Revenue Range $6.48B to $6.50B, vs. FactSet Est of $6.46B

-- Earnings Flash (WAT) Waters Corporation Posts Q3 Adjusted EPS $4.10 per Share, vs. FactSet Est of $4.00

--GUIDANCE: (WAT) Waters Expects 2026 Adjusted EPS Range $14.60 to $14.70, vs. FactSet Est of $14.59

-- GUIDANCE: (WAT) Waters Corporation Expects Q4 Revenue Range $1.80B - $1.82B

-- GUIDANCE: (WAT) Waters Corporation Expects Q4 Adjusted EPS Range $4.58 - $4.68

-- Earnings Flash (WAT) Waters Corporation Reports Q3 Revenue $1.77B, vs. FactSet Est of $1.75B

Labcorp Enters Partnership With Waters to Expand HPV Testing

Waters, Quest Diagnostics Collaborate to Expand Access to At-Home HPV Screening for Cervical Cancer